Anti-DFS70 antibodies in 597 healthy hospital workers.

OBJECTIVE Autoantibodies against DFS70 (dense fine speckles 70) antigen (also known as lens epithelium-derived growth factor) have been recently identified among the antinuclear antibodies (ANAs) in patients with atopic disorders. We undertook this study to examine the frequency of anti-DFS70 antibodies in a large number of healthy people. METHODS Sera of 597 healthy individuals working in a hospital (142 men, 455 women) were analyzed for ANAs and for anti-DFS70 antibodies by indirect immunofluorescence (IIF) with HEp-2 cells as a substrate and by immunoblotting using DFS70 recombinant protein and whole HeLa cell extract. RESULTS ANAs were present in 20% of all individuals by IIF. Nine percent of subjects were ANA positive at a serum dilution of 1:40, 4.0% at 1:80, 5.5% at 1:160, 1.0% at 1:320, and 0.3% at 1:640. There were 64 anti-DFS70 antibody-positive individuals. Surprisingly, this was 11% of the whole population and 54% of the ANA-positive population. The percentage of female anti-DFS70 antibody-positive subjects (86%; 55 of 64 subjects) was higher than the percentage of female anti-DFS70 antibody-negative subjects (75%; 398 of 533 subjects) (P < 0.05). The prevalence of anti-DFS70 antibody-positive sera decreased with increasing age (P = 0.0017). CONCLUSION Considering that anti-DFS70 antibody positivity is rare in patients with systemic autoimmune diseases, introducing the anti-DFS70 antibody examination as a screening test for ANA-positive persons could be used to rule out systemic autoimmune diseases, resulting in considerable cost-saving potential. In addition, this test defines a subpopulation of healthy people in whom long-term followup might reveal health-related implications of this finding, since anti-DFS70 antibodies have been shown to be associated with some illnesses.

[1]  M. Kazatchkine,et al.  Evidence for a restricted idiotypic and epitopic specificity of anti‐thyroglobulin autoantibodies in patients with autoimmune thyroiditis , 1991, European journal of immunology.

[2]  J. Forslid,et al.  The prevalence of antinuclear antibodies in healthy young persons and adults, comparing rat liver tissue sections with HEp-2 cells as antigen substrate. , 1994, Clinical and Experimental Rheumatology.

[3]  D. P. Singh,et al.  Detection of Cytotoxic Anti-LEDGF Autoantibodies in Atopic Dermatitis , 2002, Autoimmunity.

[4]  A. Dontas,et al.  Soluble interleukin-2 receptors and autoantibodies in the serum of healthy elderly individuals. , 1990, Autoimmunity.

[5]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[6]  J. Goudevenos,et al.  High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. , 1987, Clinical and experimental immunology.

[7]  B. Lesourd,et al.  AGE-RELATED INCREASE IN AUTOANTIBODIES , 1984, The Lancet.

[8]  T. Mets,et al.  The prevalence of autoantibodies in an elderly sub‐Saharan African population , 2002, Clinical and experimental immunology.

[9]  C. Loadholt,et al.  Autoantibodies in healthy subjects of different age groups , 1979, Mechanisms of Ageing and Development.

[10]  M. Hagiwara,et al.  Spectrum of autoantibodies against a dynamin-related protein, dymple. , 2000, Arthritis and rheumatism.

[11]  A. Coutinho,et al.  Self-reactive antibodies (natural autoantibodies) in healthy individuals. , 1998, Journal of immunological methods.

[12]  Y. Muro,et al.  Anti-annexin V antibodies and digital ischemia in patients with scleroderma. , 1999, The Journal of rheumatology.

[13]  G. Verbruggen,et al.  Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. , 1993, Clinical and experimental rheumatology.

[14]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975 .

[15]  R. Roeder,et al.  Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation , 1998, The EMBO journal.

[16]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[17]  L. Salimonu,et al.  The role of circulating immune complexes; antinuclear and rheumatoid factor autoantibodies in aging in Nigerians , 1995, Mechanisms of Ageing and Development.

[18]  K. Tung,et al.  Immunological responses of healthy elderly population. , 1982, Clinical and experimental immunology.

[19]  I. Cohen,et al.  Autoimmunization to epidermal growth factor, a component of the immunological homunculus. , 2002, Autoimmunity reviews.

[20]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[21]  K. Sugimoto,et al.  Clinical features of anti‐chromo antibodies associated with anti‐centromere antibodies , 1996, Clinical and experimental immunology.

[22]  K. Tanaka,et al.  Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: comparison with the disease frequency examined 20 years ago. , 1998, Acta dermato-venereologica.

[23]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[24]  J. Koziol,et al.  Range of antinuclear antibodies in "healthy" individuals. , 1997, Arthritis and rheumatism.

[25]  D. P. Singh,et al.  LEDGF, a survival factor, activates stress-related genes , 2002, Progress in Retinal and Eye Research.

[26]  P. Andersen.  Correlation of smooth-muscle and nuclear antibodies in normal subjects. , 1977, Clinical and experimental immunology.

[27]  R. Gittes,et al.  Autoantibodies in interstitial cystitis. , 1994, The Journal of urology.

[28]  E. Chan,et al.  Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. , 2000, The Journal of allergy and clinical immunology.

[29]  M. Fritzler,et al.  Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors. , 1985, Clinical immunology and immunopathology.

[30]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[31]  E. Cameron,et al.  Letter: Pituitary function and intermittent cytotoxic and corticosteriod therapy. , 1976, Lancet.

[32]  L. Chylack,et al.  Lens epithelium-derived growth factor: effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts. , 2000, Biochemical and biophysical research communications.

[33]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[34]  V. Gilbertsen,et al.  Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans. , 1973, Journal of immunology.

[35]  Y. Muro,et al.  Clinical features and IgG subclass distribution of anti-p80 coilin antibodies. , 1999, Journal of autoimmunity.

[36]  S. Todesco,et al.  Autoantibodies of systemic rheumatic diseases in the healthy elderly. , 1990, Gerontology.

[37]  D. Isenberg,et al.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. , 1993, Arthritis and rheumatism.

[38]  E. Chan,et al.  A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells. , 1995, Biochemical and biophysical research communications.